6SJA Stock Chart & Stats
€0.58
-€0.03(-4.13%)
At close: 4:00 PM EDT
€0.58
-€0.03(-4.13%)
Day’s Range― - ―
52-Week Range€0.50 - €2.26
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€117.26M
Enterprise Value€835.20
Total Cash (Recent Filing)€35.21M
Total Debt (Recent Filing)€403.13M
Price to Earnings (P/E)7.8
Beta0.92
Next Earnings
Oct 29, 2026EPS Estimate
-0.3Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.10
Shares Outstanding176,347,780
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€2.57Price Target Upside343.22% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.11
Revenue Forecast (FY)€1.49B
Bulls Say, Bears Say
Bulls Say
Senior Segment Margin DurabilitySustained mid-20% margins indicate SelectQuote’s agent-led, technology-enabled Senior platform has durable economics. This resilience across changing Medicare Advantage conditions supports recurring profitability even when policy volumes fluctuate.
Healthcare Services Profitability InflectionThe segment’s improving profitability, stabilized membership and operational investments create a meaningful path to stronger consolidated margins. Management’s long-term low-double-digit margin target suggests this is intended as a structural improvement.
Improving Cash Generation And Cost EfficiencyBetter operating cash flow combined with AI, automation and rightsizing initiatives should strengthen cash conversion over the next several periods. These actions can support deleveraging and improve financial flexibility if execution continues.
Bears Say
FY27 Revenue ContractionA guided double-digit revenue decline signals material pressure on customer acquisition, policy volumes or reimbursement economics. Even with planned margin gains, a smaller revenue base may limit operating leverage and slow the pace of recovery.
Medicare Advantage And IRA HeadwindsCarrier right-sizing, benefit changes and IRA-related economics represent structural industry pressures rather than isolated quarter effects. They could constrain enrollment growth and revenue for multiple periods, particularly in the Senior and Healthcare Services businesses.
High-Cost Capital StructureHigh funding costs absorb a substantial portion of operating earnings and reduce cash available for reinvestment or debt reduction. The capital structure also leaves results sensitive to refinancing conditions and makes execution on cash-flow targets more important.
SelectQuote News
6SJA FAQ
What was SelectQuote’s price range in the past 12 months?
SelectQuote lowest stock price was €0.50 and its highest was €2.26 in the past 12 months.
What is SelectQuote’s market cap?
SelectQuote’s market cap is €117.26M.
When is SelectQuote’s upcoming earnings report date?
SelectQuote’s upcoming earnings report date is Oct 29, 2026 which is in 63 days.
How were SelectQuote’s earnings last quarter?
SelectQuote released its earnings results on Aug 25, 2026. The company reported -€0.163 earnings per share for the quarter, missing the consensus estimate of -€0.141 by -€0.021.
Is SelectQuote overvalued?
According to Wall Street analysts SelectQuote’s price is currently Undervalued.
Does SelectQuote pay dividends?
SelectQuote does not currently pay dividends.
What is SelectQuote’s EPS estimate?
SelectQuote’s EPS estimate is -0.3.
How many shares outstanding does SelectQuote have?
SelectQuote has 176,347,780 shares outstanding.
What happened to SelectQuote’s price movement after its last earnings report?
SelectQuote reported an EPS of -€0.163 in its last earnings report, missing expectations of -€0.141. Following the earnings report the stock price went down -5.517%.
Which hedge fund is a major shareholder of SelectQuote?
Currently, no hedge funds are holding shares in DE:6SJA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
SelectQuote Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€2.57 (343.22% Upside)
€2.57 (343.22% Upside)
Insider Transactions
Sold Shares
Worth €3.5K over
the Last 3 Months
the Last 3 Months
News Sentiment
Bullish
Bullish news 67%
Bearish news 33%
Bearish news 33%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-68.22%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-13.36%
Trailing 12-Months
Company Description
SelectQuote
SelectQuote, Inc. operates as a tech-driven, direct-to-consumer marketplace, offering a wide spectrum of insurance products to individuals throughout the United States. These policies are underwritten by a variety of insurance carriers. The company structures its operations across three core divisions: Senior, Life, and Auto & Home. Within its Senior segment, SelectQuote provides access to a comprehensive suite of health policies, including Medicare Advantage, Medicare Supplement, and Medicare Part D plans. This segment also features ancillary coverages such as prescription drug plans, dental, vision, and hearing benefits. The Life division concentrates on term life insurance offerings, while the Auto & Home segment delivers personal automobile, homeowners', and general casualty insurance solutions. Established in 1999, SelectQuote, Inc. is headquartered in Overland Park, Kansas.
6SJA Company Deck
6SJA Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presents a balanced picture: strong execution on profitability and cash flow (notably a $44M year-over-year operating cash flow improvement, Healthcare Services inflection to a near $50M annual EBITDA run rate, and >$30M of identified cost savings) contrasted with meaningful top-line headwinds (guidance implying ~14% revenue decline in 2027), ongoing Medicare Advantage market volatility, IRA-related revenue pressure, and a relatively high-cost capital structure (~$800M at ~12%). Management is prioritizing cash generation and deleveraging over growth in fiscal 2027, which supports a constructive longer-term view but leaves notable near-term revenue and capital risks.View all DE:6SJA earnings summaries6SJA Stock 12 Month Forecast
Average Price Target
€2.57
▲(343.22% Upside)